NCT02370680View on ClinicalTrials.gov

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Cardiovascular Disease
Interventions
DRUG

Aspirin

steady-state run-in prior to Durlaza treatment

DRUG

Durlaza™

comparison of different numbers of capsules

Trial Locations (1)

21215

Platelet and Thrombosis Research, LLC, Baltimore

Sponsors
All Listed Sponsors
lead

New Haven Pharmaceuticals, Inc.

INDUSTRY